UBS Group started coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Free Report) in a report published on Friday morning, Marketbeat.com reports. The firm issued a buy rating and a $21.00 price objective on the stock.
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
Shares of Telix Pharmaceuticals Limited American Depositary Shares stock opened at $14.85 on Friday. Telix Pharmaceuticals Limited American Depositary Shares has a 12 month low of $14.81 and a 12 month high of $19.99.
See Also
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- How to Find Undervalued Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What are earnings reports?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
